CHR. HANSEN A/S: Financial statements 2022
CVR: 12516479
Source: annual report 2022, Danish Business Authority
01/09/2021 – 31/08/2022
CHR. HANSEN A/S (CVR 12516479) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 5,902,769,000 and a net result of DKK 1,210,766,000 compared with DKK 812,722,000 the year before. That is an increase of 9.1% compared with the year before. The profit margin was 20.5%. Equity in the 2022 report amounted to DKK 7,350,185,000. The solvency ratio was 62.7%. The company had 1,567 employees in the financial year.
- Revenue
- DKK 5,902,769,000
- Gross Profit
- DKK 3,628,690,000
- Profit/Loss
- DKK 1,210,766,000
- Equity
- DKK 7,350,185,000
- Total Assets
- DKK 11,715,335,000
- Employees
- 1,567
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 5.9B | 3.6B | 1.2B | 7.4B | 1567 |
| 2021 | 5.4B | 3.3B | 812.7M | 7.1B | 1528 |
| 2020 | 5.4B | 3.3B | 1.2B | 6.6B | - |
| 2019 | 5.2B | 3.3B | 1.5B | 3.8B | - |
| 2018 | 5.3B | 2.9B | 1.3B | 3.3B | - |
Official annual report
Keep an eye on CHR. HANSEN A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of November 1, 2022, Mikkel Wisborg-Møller has left the board of directors of CHR. HANSEN A/S.
CHR. HANSEN A/S has published its annual report for 2021. Revenue came to DKK 5,411,421,000, and the net result was DKK 812,722,000.
About CHR. HANSEN A/S
CHR. HANSEN A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 1988. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The company was previously named CHR. HANSEN'S LABORATORIUM DANMARK A/S and A/S PSE NR. 2770. The management consists of Morten Enggaard Rasmussen. The board consists of Rainer Chapour Lehmann (chair), Anders Lund, Helle Rexen and Lisbet Kragelund. The company is owned by NOVOZYMES A/S. The company has 1,747 employees (2026). In 2025, the company reported revenue of DKK 6,820,616,000 and a net result of DKK 2,105,477,000 compared with DKK 1,891,419,000 the year before. Equity in the 2025 report amounted to DKK 11,263,718,000.